The Technical Analyst
A SPAC I Acquisition [ASCA]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
A SPAC I Acquisition Price, Forecast, Insider, Ratings, Fundamentals & Signals
-67.14% $3.01
America/New_York / 3 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 33.47 mill |
| EPS: | -0.410 |
| P/E: | -7.34 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 11.12 mill |
| Avg Daily Volume: | 0.0306 mill |
| RATING 2024-04-03 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -7.34 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -7.34 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.966 - 4.05 ( +/- 34.68%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-02-17 | Spac (holdings) Acquisition Corp. | Buy | 2 875 000 | Warrant to purchase Class A ordinary shares |
| 2022-02-17 | Tsang Claudius | Buy | 2 875 000 | Warrant to purchase Class A ordinary shares |
| 2022-02-14 | Tsang Claudius | Buy | 0 | |
| 2022-02-14 | Abusaeri Abuzzal | Buy | 0 | |
| 2022-02-14 | Brebeck John | Buy | 0 |
| INSIDER POWER |
|---|
| 0.00 |
| Last 39 transactions |
| Buy: 5 792 629 | Sell: 482 902 |
Forecast:
16:00 - $3.07
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $3.07
Forecast 2: 16:00 - $3.07
Forecast 3: 16:00 - $3.07
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $3.01 (-67.14% ) |
| Volume | 0.525 mill |
| Avg. Vol. | 0.0306 mill |
| % of Avg. Vol | 1 715.82 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ASCA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ASCA
A SPAC I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecom industries in the United States and Asia. The company was incorporated in 2021 and is based in Singapore.
Last 10 Buy Signals
Latest Press Releases
2024-04-03 16:30:00 - Press Release
Newgenivf And A Spac I Announce Closing Of Business Combination
Newgenivf's shares and warrants are expected to begin trading on the nasdaq capital market under the tickers "nivf" and "nivfw", respectively, on april 4, 2024 new york , april 3, 2024 /prnewswire/ -- newgenivf limited ("newgen" or the "company"), a comprehensive fertility services provider in asia helping couples and individuals obtain access to fertility treatments, and a spac i acquisition corp. (nasdaq: asca) ("a spac i"), a publicly traded special purpose acquisition company, today announced the completion of their previously announced business combination (the "business combination"). the combined company will be named "newgenivf group limited" ("newgenivf group") and its shares and warrants are expected to begin trading on the nasdaq capital market under the tickers "nivf", and "nivfw", respectively, on april 4, 2024.
2024-03-05 07:30:00 - Press Release
Newgenivf And A Spac I Announce Shareholder Approval Of Business Combination
Combined company to be named newgenivf group limited new york , march 5, 2024 /prnewswire/ -- newgenivf limited ("newgen" or the "company"), a comprehensive fertility services provider in asia helping couples and individuals obtain access to fertility treatments, and a spac i acquisition corp. (nasdaq: asca) ("a spac i"), a publicly traded special purpose acquisition company, announced today that the previously announced business combination (the "business combination") was approved at an extraordinary general meeting of a spac i on march 4, 2024. complete official results of the vote will be included in a current report on form 8-k to be filed by a spac i with the u.s. securities and exchange commission (the "sec").